ImmunoIVD supplies SPOTit kits for NHS newborn SCID and SMA screening
- NHS England
- London
- Direct
- 1 April 2026 to 31 March 2028
NHS England is buying SPOTit assay kits for in-service evaluations within NHS Newborn Blood Spot screening. It re-procured the SPOTit method to keep an evaluation of Severe Combined Immuno-Deficiency (SCID) running in three screening laboratories. The new contract adds an evaluation for Spinal Muscular Atrophy (SMA).
ImmunoIVD was awarded the £3.8m contract directly in March 2026. It runs for two years, and a one-year extension could take it to March 2029.
Contract ends March 2028
- What
- Laboratory consumables, reagents and chemicals
- Buyer
- NHS England
- Supplier
- ImmunoIVD
- Value
- £3.77m
- How it was bought
- Direct
- Dates and next
- Apr 2026 to Mar 2028
- Option to Mar 2029